Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
What this study shows
TSC2 is a GAP for Rheb; loss of TSC2 raises Rheb-GTP and constitutively activates mTOR.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: In vitro; Drosophila) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | In vitro; Drosophila |
| Journal | Genes & development |
| Year | 2003 |
| Peer reviewed | Yes |
| Record last updated | 2026-08-22 |
| Source | DOI 10.1101/gad.1110003 · PMID 12869586 · Free full text (PMC196227) |
Extracted findings
| Intervention | Biochemical/genetic (TSC2 GAP activity toward Rheb) |
| Target | Rheb / TSC2 / mTOR |
| Model | In vitro; Drosophila |
| Effect | TSC2 is a GAP for Rheb; Rheb-GTP activates mTOR/S6K/4EBP1 (rapamycin-sensitive) |
In the Atlas
Related topics
More studies on this topic
- Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 (2003)
- Rheb binds and regulates the mTOR kinase (2005)
- PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase (2007)
- Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids (2010)
Learn the biology
Want to understand the biology behind this study? → Rheb — The Critical Regulator